BGP Products Operations GmbH – a Viatris Company

Tweet this page
<
2016
2017
2018
2019
2020
2021
2022
2023
>
Registration as it was on 04 Jan 2016
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

150,000€

Financial year: Jan 2015 - Dec 2015

Lobbyists (Full time equivalent)

0.75 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Mylan GmbH   (Mylan)

    EU Transparency Register

    940251520152-08 First registered on 04 Jan 2016

    Goals / Remit

    Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of around 1,400 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which nearly 50% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. Our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time.

    Main EU files targeted

    ATMP Regulation
    Clinical Trials Regulation
    Data Protection Regulation
    Medical Devices Regulation
    In-Vitro Diagnostic Regulation
    Paediatric Regulation
    Access to Innovation
    Biosimilars
    Industrial Policy
    EU Trade Policy
    Health Systems Performance Assessment
    Health Technology Assessment
    Pharmaceuticals in the environment

    Address

    Head Office
    Thurgauerstrasse 40
    Zurich 8050
    SWITZERLAND
    EU Office
    Square de Meeus 37
    Brussels 1000
    BELGIUM
  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    50%1
    25%1

    Lobbyists (Full time equivalent)

    0.75

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 04 Jan 2016

    Name Start date End Date
    Daryl Melissa ALVAREZ VILLAO 17 Feb 2024 14 Feb 2025
    Katarina GATIALOVA 29 Feb 2024 28 Feb 2025
    Mr David DELANEY 02 Mar 2023 11 Mar 2024
    Daryl Melissa ALVAREZ VILLAO 28 Jan 2023 27 Jan 2024
    Mr Victor Lino MENDONCA 26 Jan 2023 26 Jan 2024
    Katarina GATIALOVA 26 Jan 2023 26 Jan 2024
    Katarina GATIALOVA 19 Nov 2021 19 Nov 2022
    Mr David DELANEY 13 Oct 2021 13 Oct 2022
    Katarina GATIALOVA 06 Feb 2020 06 Feb 2021
    Mr Victor Lino MENDONCA 07 Jan 2020 07 Jan 2021
    Mr David DELANEY 25 Sep 2019 25 Sep 2020
    Katarina GATIALOVA 29 Jan 2019 01 Feb 2020
    Mr Victor Lino MENDONCA 30 Nov 2018 30 Nov 2019
    Mr David DELANEY 13 Jul 2018 13 Jul 2019
    Mr Paulo Jorge RODRIGUES FRANCO MENDES 29 May 2018 31 Oct 2018

    Complementary Information

    None declared

    Person in charge of EU relations

    Mr Victor Mendonca (VP Global Policy & Market Access Europe)

    Person with legal responsibility

    Mr Jacek Glinka (President Mylan Europe)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    EGA

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2015 - Dec 2015

    Lobbying costs for closed financial year

    150,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    None

    Other activities

    At European level, Mylan is committed to working in partnership with the institutions of the European Union to support policies and actions that foster positive patient outcomes and high quality medicines for all.

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard